Breast Cancer Clinical Trial

Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors

Summary

This clinical trial compares a web-based patient-reported symptom monitoring and self management portal, Young, Empowered & Strong (YES), to standard therapy in managing symptoms in adolescent and young adults breast cancer survivors. YES is a web-based portal (website) to help monitor issues or symptoms women with breast cancer may experience. YES portal may improve the quality of life of young breast cancer survivors. YES portal may help manage symptoms and provide useful information/resources.

View Full Description

Full Description

PRIMARY OBJECTIVES:

I. To determine the efficacy of the YES intervention compared to usual care in improving quality of life (QOL), as measured by the Quality of Life in Adult Cancer Survivors (QLACS) at 6-months (primary outcome).

II. To determine the efficacy of the YES intervention compared to usual care in reducing specific adolescent and young adult (AYA) breast cancer (BC) concerns and symptoms at 6-months.

III. To determine the sustainability of the effects of YES on AYA concerns, symptoms, and QOL at 9 months, after the completion of the 6-month active intervention period.

EXPLORATORY OBJECTIVE:

I. To explore potential moderators and mediators of intervention efficacy, and to explore the potential effects of the intervention on inflammatory and other biomarkers including genetic profiles.

OUTLINE: Patients are randomized to 1 to 2 groups.

GROUP A: Patients receive access to YES portal for 9 months. Patients also complete surveys at baseline and 3, 6, and 9 months.

GROUP B: Patients receive usual care for 9 months. Patients also complete surveys at baseline and 3, 6, and 9 months. After 9 months, patients may also receive access to YES portal for 3 months.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Female
Age 15-39 years at diagnosis of a stage 0-III breast cancer
Within 3 years of breast cancer diagnosis
No known evidence of breast cancer recurrence (local or distant) or second primary breast cancer
No prior history of new other malignancy since their breast cancer diagnosis (other than non-melanoma skin cancer)
Able to speak, understand and read English
Cognitively able to complete the study requirements
Ability to access medical records from treating hospital
Willing to provide cell phone number and/or email address, and willing to receive email and/or text messages from the study team either with their own smartphone or one provided by the study team if they do not have their own to use
Pregnant survivors are also eligible for this protocol, given that fertility and pregnancy are important AYA issues

Exclusion Criteria:

Individuals under age 15 or over age 42
Stage IV or metastatic breast cancer
Males with breast cancer are not being recruited to this protocol. In the AYA age group, only a miniscule proportion of breast cancers occur in males. For this reason, the YES portal intervention materials have been targeted for young women

Study is for people with:

Breast Cancer

Estimated Enrollment:

360

Study ID:

NCT04906200

Recruitment Status:

Recruiting

Sponsor:

Ohio State University Comprehensive Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

Dana Farber Cancer Institute
Boston Massachusetts, 02215, United States More Info
Ann Partridge, M.D.
Contact
617-582-7942
[email protected]
Craig Snow, MHA
Contact
617-582-7942
[email protected]
Ann H Partridge, MD
Principal Investigator
Columbia University Medical Center
New York New York, 10032, United States More Info
Dawn Hershman, MD, MS
Contact
212-305-1945
[email protected]
Ohio State University Comprehensive Cancer Center
Columbus Ohio, 43210, United States More Info
Michelle Naughton, PhD
Contact
614-293-6390
[email protected]
Michelle Naughton, PhD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

360

Study ID:

NCT04906200

Recruitment Status:

Recruiting

Sponsor:


Ohio State University Comprehensive Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider